Credit Suisse’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-2
| Closed | -$10K | – | 3498 |
|
|
2017
Q1 | $10K | Sell |
2
-2
| -50% | -$10K | ﹤0.01% | 3403 |
|
|
2016
Q4 | $29K | Buy |
4
+1
| +33% | +$7.25K | ﹤0.01% | 3692 |
|
|
2016
Q3 | $49K | Sell |
3
-1
| -25% | -$16.3K | ﹤0.01% | 3679 |
|
|
2016
Q2 | $58K | Sell |
4
-18
| -82% | -$261K | ﹤0.01% | 3828 |
|
|
2016
Q1 | $459K | Buy |
22
+15
| +214% | +$313K | ﹤0.01% | 2997 |
|
|
2015
Q4 | $141K | Buy |
+7
| New | +$141K | ﹤0.01% | 3781 |
|
|
2015
Q2 | – | Sell |
-11
| Closed | -$213K | – | 4279 |
|
|
2015
Q1 | $213K | Buy |
+11
| New | +$213K | ﹤0.01% | 3773 |
|
|
2014
Q2 | – | Sell |
-8
| Closed | -$176K | – | 4308 |
|
|
2014
Q1 | $176K | Buy |
+8
| New | +$176K | ﹤0.01% | 4020 |
|